Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Matthias Barral is a leading figure in interventional oncology, specializing in the development and application of robotic systems for minimally invasive cancer treatments. His research focuses on advancing percutaneous liver and prostate interventions, where he has made significant contributions to improving precision and patient outcomes. Notably, his systematic review on robotic-guided liver interventions (32 citations) provides a critical evaluation of emerging clinical solutions, while his 2024 update on interventional oncology (19 citations) explores the transformative role of artificial intelligence in cancer care. Dr. Barral’s work on in-bore transrectal MRI-guided biopsy with robotic assistance demonstrated a 100% technical success rate and high cancer detection rates, showcasing his impact on prostate cancer diagnostics. He also compared robot-assisted partial nephrectomy with percutaneous ablation for renal cell cancer in elderly patients, highlighting his commitment to optimizing treatments for vulnerable populations. With a growing citation record and a focus on translating cutting-edge technology into clinical practice, Dr. Barral is shaping the future of interventional oncology.